Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies: comment.
Hideo WadaTakeshi MatsumotoYoshiki YamashitaKohshi OhishiMakoto IkejiriNaoyuki KatayamaPublished in: Journal of thrombosis and haemostasis : JTH (2019)
Keyphrases